| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac07412a3fcd0990ac60cc7a574a768c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfa7afde663fb62777b919bd04b16f9c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2531-113 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6895 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2017-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d23b77f485cbce91e479a98f515e7145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b25961febc092c2832dd847ce3c9e490 |
| publicationDate |
2018-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101833503-B1 |
| titleOfInvention |
Method for diagnosis of lung cancer in chronic obstructive pulmonary disease patients using analysis of bacteria metagenome |
| abstract |
The present invention relates to a method for providing information on the diagnosis of lung cancer through the analysis of a bacterial meta genome, and more specifically, by analyzing a bacterial metagenome using a sample derived from a subject to analyze the increase or decrease of the content of a specific bacterium- The present invention relates to a method of predicting the risk of developing lung cancer or diagnosing lung cancer in a patient with chronic obstructive pulmonary disease. Since the extracellular vesicles released from the germs present in the environment are absorbed into the body to directly affect the cancer development and since it is difficult to diagnose lung cancer before the onset of symptoms, The preliminary prediction of the risk of lung cancer through the analysis of the bacterial metagenome present in the germ-derived extracellular vesicles present in the bacterium enables early diagnosis and prediction of the risk group of lung cancer, thereby delaying the onset of the disease, Early diagnosis can be made even after the onset, which can lower the incidence of lung cancer and improve the treatment effect. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210096963-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190105517-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113286897-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102185985-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102118197-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020145663-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190103962-A |
| priorityDate |
2016-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |